Phosphohistidine cannot replace phosphotyrosine in high-affinity binding to PI/PTB or SH2 domains

被引：0
|
作者：
Senderowicz, L
Wang, JX
Wang, LY
Yoshizawa, S
Kavanaugh, WM
Turck, CW
机构：
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Chiron Corp, Emeryville, CA 94608 USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1890
引用
收藏
页码：A1180 / A1180
页数：1
相关论文
共 50 条
  • [31] SH2 Domains: Folding, Binding and Therapeutical Approaches
    Diop, Awa
    Santorelli, Daniele
    Malagrino, Francesca
    Nardella, Caterina
    Pennacchietti, Valeria
    Pagano, Livia
    Marcocci, Lucia
    Pietrangeli, Paola
    Gianni, Stefano
    Toto, Angelo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [32] Correlation between dynamics and high affinity binding in an SH2 domain interaction
    Kay, LE
    Muhandiram, DR
    Farrow, NA
    Aubin, Y
    FormanKay, JD
    BIOCHEMISTRY, 1996, 35 (02) : 361 - 368
  • [33] Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains
    Zhang, Mingzhen
    Jang, Hyunbum
    Gaponenko, Vadim
    Nussinov, Ruth
    BIOPHYSICAL JOURNAL, 2017, 113 (09) : 1956 - 1967
  • [34] RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2
    María Jesús Lorenzo
    Gerald D Gish
    Carol Houghton
    Timothy J Stonehouse
    Tony Pawson
    Bruce AJ Ponder
    Darrin P Smith
    Oncogene, 1997, 14 : 763 - 771
  • [35] RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2
    Lorenzo, MJ
    Gish, GD
    Houghton, C
    Stonehouse, TJ
    Pawson, T
    Ponder, BAJ
    Smith, DP
    ONCOGENE, 1997, 14 (07) : 763 - 771
  • [36] Small ligands interacting with the phosphotyrosine binding pocket of the Src SH2 protein
    Deprez, P
    Mandine, E
    Gofflo, D
    Meunier, S
    Lesuisse, D
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) : 1295 - 1298
  • [37] Phosphotyrosine containing dipeptides as high affinity ligands of p56lck SH2 domain.
    Beaulieu, PL
    Cameron, DR
    Ferland, JM
    Gauthier, J
    Ghiro, E
    Gillard, J
    Rancourt, VGJ
    Wernic, D
    Llinas-Brunet, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U280 - U280
  • [38] X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor
    Bohacek, RS
    Dalgarno, DC
    Hatada, M
    Jacobsen, VA
    Lynch, BA
    Macek, KJ
    Merry, T
    Metcalf, CA
    Narula, SS
    Sawyer, TK
    Shakespeare, WC
    Violette, SM
    Weigele, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) : 660 - 663
  • [39] Novel Roles of SH2 and SH3 Domains in Lipid Binding
    Sipeki, Szabolcs
    Koprivanacz, Kitti
    Takacs, Tamas
    Kurilla, Anita
    Laszlo, Loretta
    Vas, Virag
    Buday, Laszlo
    CELLS, 2021, 10 (05)
  • [40] The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin β cytoplasmic domains
    Woodside, DG
    Obergfell, A
    Talapatra, A
    Calderwood, DA
    Shattil, SJ
    Ginsberg, MH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39401 - 39408
12345